A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy
AbbVie
AbbVie
Daiichi Sankyo
Amgen
Jazz Pharmaceuticals
Pfizer
Novartis
Children's Oncology Group
Amgen Research (Munich) GmbH